National Trends in the Management and Survival of Surgically Managed Gallbladder Adenocarcinoma Over 15 years: A Population-Based Analysis

Journal of Gastrointestinal Surgery

Volumn 14, Issue 10, 2010, Pages 1578-1591

  Mayo, Skye C ^a   Shore, Andrew D ^b   Nathan, Hari ^a   Edil, Barish ^a   Wolfgang, Christopher L ^a   Hirose, Kenzo ^a   Herman, Joseph ^c   Schulick, Richard D ^a   Choti, Michael A ^a   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Gallbladder cancer; Medicare; SEER; Surgery; Survival

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; CANCER REGISTRY; CHOLECYSTECTOMY; FEMALE; GALLBLADDER TUMOR; HUMAN; LIVER RESECTION; LYMPHADENECTOMY; MALE; MORTALITY; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; SURVIVAL; UNITED STATES;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CHOLECYSTECTOMY; FEMALE; GALLBLADDER NEOPLASMS; GUIDELINE ADHERENCE; HEPATECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES;

EID: 77957019392     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1335-3     Document Type: Article

References (51)

1. Horner MJ RL, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD. Available at: http://seer. cancer. gov/csr/1975_2006/. Based on November 2008 SEER data submission, posted to the SEER web site, 2009.
2. Shih SP, Schulick RD, Cameron JL, et al. Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg 2007; 245(6): 893-901.
3. Fong Y, Malhotra S. Gallbladder cancer: recent advances and current guidelines for surgical therapy. Adv Surg 2001; 35: 1-20.
4. Foster JM, Hoshi H, Gibbs JF, et al. Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection. Ann Surg Oncol 2007; 14(2): 833-840.
5. Chan SY, Poon RT, Lo CM, et al. Management of carcinoma of the gallbladder: a single-institution experience in 16 years. J Surg Oncol 2008; 97(2): 156-164.
6. Balachandran P, Agarwal S, Krishnani N, et al. Predictors of long-term survival in patients with gallbladder cancer. J Gastrointest Surg 2006; 10(6): 848-854.
7. Dixon E, Vollmer CM, Jr., Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg 2005; 241(3): 385-394.
8. Pawlik TM, Gleisner AL, Vigano L, et al. Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg 2007; 11(11): 1478-86; discussion 1486-7.
9. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) Hepatobiliary Cancers. (Version 1. 2010). © 2010. Available at: www. NCCN. org. Accessed 8 April 2010.
10. American Joint Commission on Cancer (2010) American Cancer Society, 7th ed. New York, NY: Springer.
11. Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Ann Surg 1994; 219(3): 275-280.
12. Kokudo N, Makuuchi M, Natori T, et al. Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg 2003; 138(7): 741-750; discussion 750.
13. D'Angelica M, Brennan MF, Fortner JG, et al. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg 1997; 185(6): 554-559.
14. Konstantinidis IT, Deshpande V, Genevay M, et al. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg 2009; 144(5): 441-447; discussion 447.
15. Wise PE, Shi YY, Washington MK, et al. Radical resection improves survival for patients with pT2 gallbladder carcinoma. Am Surg 2001; 67(11): 1041-1047.
16. Jensen EH, Abraham A, Habermann EB, et al. A critical analysis of the surgical management of early-stage gallbladder cancer in the United States. J Gastrointest Surg 2009; 13(4): 722-727.
17. Jensen EH, Abraham A, Jarosek S, et al. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer. Surgery 2009; 146(4): 706-711; discussion 711-3.
18. Coburn NG, Cleary SP, Tan JC, et al. Surgery for gallbladder cancer: a population-based analysis. J Am Coll Surg 2008; 207(3): 371-382.
19. Cooper GS, Virnig B, Klabunde CN, et al. Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002; 40(8 Suppl): IV-43-8.
20. National Cancer Institute D, Surveillance Research Program, Cancer Statistics Branch. Surveillance, epidemiology, and end results (SEER) program. Available at: (http://www. seer. cancer. gov). SEER* Stat database: Incidence, SEER 17 regs public-use, Nov 2005 sub (1973-2003 varying), linked to county attributes, total US, 1969-2003 counties. Released April 2006, based on the November 2005 submission.
21. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002; 40(8 Suppl): IV-3-18.
22. Fritz AG. International Classification of Diseases for Oncology: ICD-O, 3rd ed. Geneva: World Health Organization 2000.
23. American Joint Commission on Cancer, American Cancer Society. 6th ed. New York: Springer, 2002.
24. SEER program coding and staging manual. Bethesda, MD: National Cancer Institute, 2007.
25. Morris AM, Baldwin LM, Matthews B, et al. Reoperation as a quality indicator in colorectal surgery: a population-based analysis. Ann Surg 2007; 245(1): 73-79.
26. Potosky AL, Warren JL, Riedel ER, et al. Measuring complications of cancer treatment using the SEER-Medicare data. Med Care 2002; 40(8 Suppl): IV-62-8.
27. Kaplan EL MP. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
28. Cox D. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.
29. Hosmer DW, Lemeshow S. Applied Survival Analysis: Regression modeling of time to event data. 2nd ed. New York: John Wiley and Sons, Inc., 1999.
30. May S, Hosmer DW. A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model. Lifetime Data Anal 1998; 4(2): 109-120.
31. Agresti A. Introduction to categorical data analysis. New York: Wiley, 1996. pp. 231-236.
32. Nathan H, Pawlik TM. Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol 2008; 15(2): 415-423.
33. Kim SJ, Lee JM, Lee JY, et al. Accuracy of preoperative T-staging of gallbladder carcinoma using MDCT. AJR Am J Roentgenol 2008; 190(1): 74-80.
34. Rao ND, Gulati MS, Paul SB, et al. Three-dimensional helical computed tomography cholangiography with minimum intensity projection in gallbladder carcinoma patients with obstructive jaundice: comparison with magnetic resonance cholangiography and percutaneous transhepatic cholangiography. J Gastroenterol Hepatol 2005; 20(2): 304-308.
35. Park HS, Lee JM, Choi HK, et al. Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 2009; 30(3): 586-595.
36. Manfredi R, Mehrabi S, Motton M, et al. MR imaging and MR cholangiopancreatography of multifocal intraductal papillary mucinous neoplasms of the side branches: MR pattern and its evolution. Radiol Med 2008; 113(3): 414-428.
37. Guiu B, Loffroy R, Ben Salem D, et al. Combined SPIO-gadolinium magnetic resonance imaging in cirrhotic patients: negative predictive value and role in screening for hepatocellular carcinoma. Abdom Imaging 2008; 33(5): 520-528.
38. Hueman MT, Vollmer CM, Jr., Pawlik TM. Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol 2009; 16(8): 2101-2115.
39. Corvera CU, Blumgart LH, Akhurst T, et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 2008; 206(1): 57-65.
40. Pawlik TM, Choti MA. Biology dictates prognosis following resection of gallbladder carcinoma: sometimes less is more. Ann Surg Oncol. 2009; 16(4): 787-788.
41. D'Angelica M, Dalal KM, DeMatteo RP, et al. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol 2009; 16(4): 806-816.
42. Tsao JI, Loftus JP, Nagorney DM, et al. Trends in morbidity and mortality of hepatic resection for malignancy. A matched comparative analysis. Ann Surg 1994; 220(2): 199-205.
43. Thompson HH, Tompkins RK, Longmire WP, Jr. Major hepatic resection. A 25-year experience. Ann Surg 1983; 197(4): 375-388.
44. Bentrem DJ, Dematteo RP, Blumgart LH. Surgical therapy for metastatic disease to the liver. Annu Rev Med 2005; 56: 139-156.
45. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230(3): 309-318; discussion 318-21.
46. Bozzetti F, Gennari L, Regalia E, et al. Morbidity and mortality after surgical resection of liver tumors. Analysis of 229 cases. Hepatogastroenterology 1992; 39(3): 237-241.
47. Taylor M, Forster J, Langer B, et al. A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg 1997; 173(6): 467-471.
48. Capussotti L, Polastri R. Operative risks of major hepatic resections. Hepatogastroenterology 1998; 45(19): 184-190.
49. Asiyanbola B, Chang D, Gleisner AL, et al. Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg 2008; 12(5): 842-851.
50. Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 2000; 232(4): 557-569.
51. Wright BE, Lee CC, Iddings DM, et al. Management of T2 gallbladder cancer: are practice patterns consistent with national recommendations? Am J Surg 2007; 194(6): 820-825; discussion 825-6.